Startups
Andelyn Biosciences is a biopharmaceutical CDMO Pioneering Solutions That Turn Hope into Reality™
Overview
Location
United States, Ohio, Columbus
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 31, 2025 | Hubble Therapeutics: $7.3 Million (Series A) Raised For Developing Gene Therapy Cure For LCA16 | Hubble Therapeutics, a patient-focused biotechnology company developing a gene therapy to cure pediatric blindness, announced the closing of a $7.3 million Series A funding round, which will advance its lead candidate, HUB-101, into human c... |
| Aug 6, 2024 | Andelyn Biosciences Expands AAV Curator™ Platform Offering to Include MyoAAV Plasmids through a License Agreement from the Broad Institute of MIT and Harvard | COLUMBUS, Ohio, Aug. 6, 2024 /PRNewswire/ -- Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has entered into a License Agreement with the Broad Inst... |
| Mar 25, 2024 | Andelyn Biosciences and Grace Science, LLC Partner to Tech Transfer Phase I/II/III Manufacturing of a Suspension Process Adeno-Associated Virus (AAV) Gene Therapy for NGLY1 Deficiency | COLUMBUS, Ohio, March 25, 2024 /PRNewswire/ -- Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Grace Science, LLC, to tech tran... |
Reviews 0
FAQ about Andelyn Biosciences
What has the press written about Andelyn Biosciences?
Parsers VC has collected 4 articles mentioning Andelyn Biosciences, among them “Hubble Therapeutics: $7.3 Million (Series A) Raised For Developing Gene Therapy Cure For LCA16” (Mar 31, 2025) and “Andelyn Biosciences Expands AAV Curator™ Platform Offering to Include MyoAAV Plasmids through a License Agreement from the Broad Institute of MIT and Harvard” (Aug 6, 2024).
Is Andelyn Biosciences still active?
Yes, Andelyn Biosciences is active; its latest activity on Parsers VC dates from May 28, 2025.